MELA Sciences (MELA) Reports Q1 Loss of $1.12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
MELA Sciences Reports First Quarter 2015 Financial Results
May 14, 2015 8:03 AM EDTIRVINGTON, N.Y., May 14, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq: MELA), developer of the MelaFind® System, a non-invasive software-driven image analysis device intended to provide a dermatologist with objective data of clinically irregular pigmented moles when they choose to obtain additional information to help them decide whether or not to biopsy (at the most curable and cost-effective stage), today reported financial results for the quarter ended March 31, 2015.
First Quarter 2015 Financial Results Compared with... More



